activity
20242026
most citedLeveraging Biomolecule and Natural Language through Multi-Modal Learning: A Survey

5 citations · 5 across the 2 of their papers we have counts for

collaborators

8 papers

q-bio.BM2026

Deciphering Scientific Reasoning Steps from Outcome Data for Molecule Optimization

Zequn Liu, Kehan Wu, Shufang Xie +5

Emerging reasoning models hold promise for automating scientific discovery. However, their training is hindered by a critical supervision gap: experimental outcomes are abundant, w…

cs.CL2025

Leveraging Biomolecule and Natural Language through Multi-Modal Learning: A Survey

Qizhi Pei, Zhimeng Zhou, Kaiyuan Gao +6

The integration of biomolecular modeling with natural language (BL) has emerged as a promising interdisciplinary area at the intersection of artificial intelligence, chemistry and…

cs.AI2025

MolChord: Structure-Sequence Alignment for Protein-Guided Drug Design

Wei Zhang, Zekun Guo, Yingce Xia +4

Structure-based drug design (SBDD), which maps target proteins to candidate molecular ligands, is a fundamental task in drug discovery. Effectively aligning protein structural repr…

cs.AI2025

Nature Language Model: Deciphering the Language of Nature for Scientific Discovery

Yingce Xia, Peiran Jin, Shufang Xie +43

Foundation models have revolutionized natural language processing and artificial intelligence, significantly enhancing how machines comprehend and generate human languages. Inspire…

q-bio.BM2025

FABind+: Enhancing Molecular Docking through Improved Pocket Prediction and Pose Generation

Kaiyuan Gao, Qizhi Pei, Gongbo Zhang +3

Molecular docking is a pivotal process in drug discovery. While traditional techniques rely on extensive sampling and simulation governed by physical principles, these methods are…

q-bio.QM2024

MIN: Multi-channel Interaction Network for Drug-Target Interaction with Protein Distillation

Shuqi Li, Shufang Xie, Hongda Sun +4

Traditional drug discovery processes are both time-consuming and require extensive professional expertise. With the accumulation of drug-target interaction (DTI) data from experime…